Accelerating drug discovery: Open source cancer cell biology?
- PMID: 17097556
- DOI: 10.1016/j.ccr.2006.10.011
Accelerating drug discovery: Open source cancer cell biology?
Abstract
The possibility that experimental data from diverse cell biology experiments might shed light on other experiments has been generally outside the realm of cancer biologists. Recent experiments suggest that core RNA expression profiles distilled from experiments using a set of known members with related attributes may be used as query tools to probe expression profiles from other unrelated experiments. The potential benefit arises from the possibility to share findings without fully reconstructing the exact initial conditions. The limitations will be framed by the robustness of the hypotheses so generated.
Comment on
-
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance.Cancer Cell. 2006 Oct;10(4):331-42. doi: 10.1016/j.ccr.2006.09.006. Epub 2006 Sep 28. Cancer Cell. 2006. PMID: 17010674
-
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators.Cancer Cell. 2006 Oct;10(4):321-30. doi: 10.1016/j.ccr.2006.09.005. Epub 2006 Sep 28. Cancer Cell. 2006. PMID: 17010675
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
